SCHEMBL2069406

SCHEMBL2069406

Cc1noc(CS(=O)(=O)c2ccccc2)n1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 8/20 0.49
▸ RAB9A P51151 7/20 0.49
▸ ALDH1A1 P00352 5/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ SLC6A3 Q01959 1/20 0.48
▸ SMN1; SMN2 Q16637 8/20 0.47
▸ LMNA P02545 1/20 0.47
▸ PSIP1 O75475 1/20 0.44
▸ MAPT P10636 2/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ KCNJ1 P48048 1/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ HTT P42858 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ KDM1A O60341 1/20 0.42
▸ MAOA P21397 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2069565 0.83 EDNRB (0.45) NPC1RAB9AALDH1A1SMN1; SMN2LMNA
SCHEMBL2071610 0.80 NPC1 (0.43) NPC1RAB9AALDH1A1TDP1SMN1; SMN2
SCHEMBL2070164 0.79 MAPT (0.58) NPC1RAB9AALDH1A1TDP1SMN1; SMN2
SCHEMBL2069643 0.76 POLB (0.42) NPC1RAB9AALDH1A1SMN1; SMN2LMNA
SCHEMBL2069838 0.74 NPC1 (0.52) NPC1RAB9AALDH1A1TDP1SMN1; SMN2
SCHEMBL22639780 0.74 KDM1A (0.48) ALDH1A1SLC6A3SMN1; SMN2MAPTCYP2C9
SCHEMBL2069438 0.72 NPC1 (0.65) NPC1RAB9AALDH1A1TDP1SMN1; SMN2
SCHEMBL2070345 0.71 MAPT (0.51) NPC1RAB9AALDH1A1TDP1SMN1; SMN2
SCHEMBL11339875 0.69 NPC1 (0.51) NPC1RAB9AALDH1A1TDP1SMN1; SMN2
SCHEMBL9820058 0.68 MAPT (0.61) ALDH1A1TDP1PSIP1MAPTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1938273-B Tetrahydrocarbazoles and derivatives HOFFMAN-LA ROCHE LTD. (CH) 2011-12-14 — — CN disclosed
US-7906546-B2 Tetrahydrocarbazoles and derivatives HOFFMANN-LA ROCHE INC. (US) 2011-03-15 — — US disclosed
US-20100216833-A1 TETRAHYDROCARBAZOLES AND DERIVATIVES DEHMLOW HENRIETTA 2010-08-26 — — US disclosed
EP-1732892-B1 TETRAHYDROCARBAZOLES AND DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-09-17 — — EP disclosed
CN-1938273-A Tetrahydrocarbazoles and derivatives HOFFMANN LA ROCHE (CH) 2007-03-28 — — CN disclosed
EP-1732892-A1 TETRAHYDROCARBAZOLES AND DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2006-12-20 — — EP disclosed
WO-2005092856-A1 TETRAHYDROCARBAZOLES AND DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-10-06 — — WO disclosed
US-20050215577-A1 Tetrahydrocarbazoles and derivatives HOFFMANN-LA ROCHE INC. 2005-09-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216833-A1 TETRAHYDROCARBAZOLES AND DERIVATIVES NR1H3, NR1H2, NR1H4 NPC1 92/4885RAB9A 3611/4885ALDH1A1 3812/4885
US-20050215577-A1 Tetrahydrocarbazoles and derivatives NR1H3, NR1H2, NR1H4 NPC1 92/4885RAB9A 3611/4885ALDH1A1 3812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback